Creative Diagnostics Introduces Innovative Exosome Quantification Immunoassay Kits
SHIRLEY, NY, UNITED STATES - Jul 17, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics announces that it has developed and optimized an innovative technology (ExoAssay) that allows specific capture of exosomes from different biological samples, including cell culture supernatants and human biological fluids (plasma, serum, urine, saliva). Exosome Quantification Immunoassay Kits are available in two formats which include ExoAssay ELISA Kits for colorimetric detection and ExoAssay CLIA Kits for luminometric detection.
Exosomes are small cell-derived vesicles of 40-100 nm in size of endocytic origin. Although initially merely regarded as cellular excretion bodies, exosomes are indeed key components of intercellular communication. Practically every cell secretes exosomes and these nanovesicles are representatives of the cell from which they originate.
Now Creative Diagnostics offers ExoAssay for all researchers, which is a patented double sandwich immunoassay for quantitative and qualitative analysis of exosomes. ExoAssay is a particularly successful platform for exosomes quantification and characterization from small amount of human biological fluids or cell media and it may be exploited to identify exosomes released by cancer cells in the plasma and urine of tumor patients in various disease conditions.
"A global company, Creative Diagnostics continues to expand its immunoassays offering with these new ExoAssay ELISA Kits, which allow for the quantitative determination of exosomes. These ELISA kits provide a highly sensitive measurement and provide fully quantitative results for researchers. To make our ELISA kits meet clients' needs for rapid, high-throughput analysis, our professional team will develop and deploy ELISA kits products and services, and we believe we have the ability to meet the ever-changing and rapidly growing needs of life science industry." says Prof. Mike Knuth, M.D., the chief scientific officer of R&D department of Creative Diagnostics.
"Based on years of successful experience, Creative Diagnostics always focuses on providing innovative life science research reagents for global customers. The exosome quantification immunoassay kits and our ExoAssay technology are a useful tool for exosomes quantification and characterization and will help our clients advance the studies on exosomes. Our strong portfolio of assay kits will support the life science community to make more breakthroughs." says Dr. Jessica Waldorf, chief scientific officer of R&D department of Creative Diagnostics.
If you want to know more information about the Exosome Quantification Immunoassay Kits or other new products, please contact Creative Diagnostics at 1-631-619-7922 or email to contact@creative-diagnostics.com.
About Creative Diagnostics
Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components and critical assay reagents. It also provides contract biologic R&D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. It aims to provide a trusted source for all researchers' assay development and manufacturing needs